Provided by Tiger Trade Technology Pte. Ltd.

Tema Heart & Health ETF

35.80
-0.0478-0.13%
Post-market: 35.68-0.1239-0.35%19:30 EDT
Volume:1K
Turnover:45.58K
Market Cap:52.99M
PE:- -
High:35.80
Open:35.68
Low:35.68
Close:35.85
52wk High:38.87
52wk Low:31.87
Shares:1.48M
Float Shares:1.48M
Volume Ratio:0.73
T/O Rate:0.09%
Dividend:0.47
Dividend Rate:1.32%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS
·
Sep 30

US Drug Lobby Group PhRMA Names Former House Leader Cantor as CEO

Reuters
·
Sep 30

Cboe data shows mixed options sentiment in UnitedHealth with shares down 1.58%

TIPRANKS
·
Sep 30

Cigna: Announces Exclusive Agreement with UnitedHealth Global to Endorse Ghb as Preferred International Health Insurer - Website

THOMSON REUTERS
·
Sep 29

Cigna Global Health Benefits Signs Exclusive Endorsement Deal with UnitedHealthcare Global

Reuters
·
Sep 29

Roche's New Breast-Cancer Drug Supports Midterm Growth Outlook

Dow Jones
·
Sep 29

Roche Shows New Research-and-Development Approach is Bearing Fruit

Dow Jones
·
Sep 29

Roche Dashes Hopes of Guidance Upgrade

Dow Jones
·
Sep 29

Roche Needs Next Drug Launches to Go Smoothly

Dow Jones
·
Sep 29

Roche Signals it is Too Soon to Know if AI Improves Trial Success Rates

Dow Jones
·
Sep 29

Roche Seems Increasingly Confident in Obesity Portfolio

Dow Jones
·
Sep 29

Eli Lilly Reports Zepbound Showed 4.5% Greater Weight Loss Than Novo Nordisk's Wegovy HD

MT Newswires Live
·
Sep 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 29

Eli Lilly’s Zepbound shows improved weight loss vs. Wegovy in new analysis

TIPRANKS
·
Sep 29

Eli Lilly - Zepbound 10 Mg and 15 Mg Show Comparable Adverse Event Discontinuation Rates to Wegovy Hd

THOMSON REUTERS
·
Sep 29

Eli Lilly - Zepbound 15 Mg Shows 4.5% Greater Weight Loss than Wegovy Hd in Adults with Obesity

THOMSON REUTERS
·
Sep 29

Lilly's Zepbound (Tirzepatide 10 Mg and 15 Mg) was Associated with More Weight Loss than Wegovy Hd (Semaglutide Injection 7.2 Mg) in a New Indirect Treatment Comparison

THOMSON REUTERS
·
Sep 29

Eli Lilly - Zepbound Achieves 20.2% Weight Reduction vs 13.7% for Wegovy at 72 Weeks

THOMSON REUTERS
·
Sep 29

Eli Lilly - Zepbound 15 Mg Users Have over Three Times the Odds of 20% Weight Reduction vs Wegovy Hd

THOMSON REUTERS
·
Sep 29

Citi Remains a Hold on Merck & Company (MRK)

TIPRANKS
·
Sep 29